Physician profile
Selin Sendil
NPI 1780188904
$7,295.00
in general payments reported to CMS, 2019-2025
15 companies · $5,838 in 2025
The $5,838 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $386 · 2023: $258 · 2024: $620 · 2025: $5,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,825 · Food and Beverage: $2,627 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,825.12 |
| Food and Beverage | $2,627.05 |
| Education | $264.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,624.04 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| W. L. Gore & Associates, INC. | $1,622.24 | 2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Edwards Lifesciences Corporation | $1,489.70 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $477.01 | 2022-2024 | Aveir, Assurity, Cardiomems |
| Shockwave Medical, INC | $350.86 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.86 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $121.14 | 2022-2024 | Wainua |
| Chiesi USA, INC. | $83.64 | 2024 | Kengreal |
| Acist Medical Systems, INC. | $72.93 | 2025 | |
| Pfizer INC. | $67.84 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $59.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $49.16 | 2024 | |
| Amgen INC. | $40.58 | 2024 | Repatha |
| Terumo Medical Corporation | $33.41 | 2023 | Tr Band, Heartrail, Angio-Seal |
| E.R. Squibb & Sons, L.L.C. | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selin Sendil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.